Alexandria Real Estate Equities
ARE
#2372
Rank
A$11.20 B
Marketcap
A$65.13
Share price
-0.20%
Change (1 day)
-43.35%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) - Net assets

Net assets on the balance sheet as of June 2026 : A$27.44 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company has A$27.44 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alexandria Real Estate Equities - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$28.60 B-20.58%
2024-12-31$A$36.01 B8.45%
2023-12-31$A$33.20 B-0.38%
2022-12-31$A$33.33 B26.97%
2021-12-31$A$26.25 B50.16%
2020-12-31$A$17.48 B20.41%
2019-12-31$A$14.52 B29.57%
2018-12-31$A$11.20 B34.95%
2017-12-31$A$8.30 B11.22%
2016-12-31$A$7.46 B26.68%
2015-12-31$A$5.89 B23.39%
2014-12-31$A$4.77 B7.09%
2013-12-31$A$4.46 B32.33%
2012-12-31$A$3.37 B0.68%
2011-12-31$A$3.34 B13.88%
2010-12-31$A$2.93 B9.76%
2009-12-31$A$2.67 B8.53%
2008-12-31$A$2.46 B43.47%
2007-12-31$A$1.72 B-3.78%
2006-12-31$A$1.78 B53.89%
2005-12-31$A$1.16 B44.87%
2004-12-31$A$0.80 B17.52%
2003-12-31$A$0.68 B-20.88%
2002-12-31$A$0.86 B32.31%
2001-12-31$A$0.65 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$122.34 B 345.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.48 B 76.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.72 B-39.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$16.80 B-38.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$3.82 B-86.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$31.94 B 16.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.93 B-92.94%๐Ÿ‡บ๐Ÿ‡ธ USA